Quantcast

Latest Denosumab Stories

2014-12-08 08:31:08

This Approval Provides a New Treatment Option for a Patient Population With High Unmet Medical Need THOUSAND OAKS, Calif., Dec.

2014-10-28 08:35:52

Plans to Payout Approximately 60 Percent of Adjusted Net Income on Average to Shareholders Through 2018 NEW YORK, Oct.

2014-09-15 16:29:02

Data Presented at the American Society of Bone and Mineral Research 2014 Annual Meeting THOUSAND OAKS, Calif., Sept.

2014-09-15 16:28:40

Romosozumab Currently in Phase 3 Clinical Development, Pivotal Data Expected in 2016 THOUSAND OAKS, Calif. and BRUSSELS, Sept.

2014-09-10 08:32:41

Data Include Eight Year Analyses of Bone Mineral Density Results for Prolia® (Denosumab) and Further Evidence for Significant Bone-Building With Romosozumab THOUSAND OAKS, Calif., Sept.

2014-05-27 16:25:23

New Data Reinforces Commitment to Personalized Medicine and Highlights Advances in Immunotherapy Platform THOUSAND OAKS, Calif.

2013-12-03 11:15:50

A study comparing the efficacy and tolerability of two popular osteoporosis drugs, denosumab and zoledronic acid, found that denosumab had a significantly greater effect on increasing spine bone mineral density and zoledronic acid caused more flulike symptoms.

2013-09-12 23:18:41

Transparency Market Research published new "Global Osteoporosis Drug Market- China Industry Analysis, Size, Share, Growth, Trends and Forecast, 2010 - 2015" market research report to


Word of the Day
orbity
  • A bereavement by loss of parents or children; the state of being orbate; orbation.
The word 'orbity' ultimately comes from a Latin word meaning 'bereaved'.